Max Robotics — Global Service Robot Directory + US Certification

About

Yoshihiko Hirao is a leading figure in urologic oncology, with a career dedicated to advancing the understanding and treatment of prostate cancer, particularly within the Asian context. His primary research areas encompass the epidemiology, clinical management, and surgical outcomes of prostate cancer, with a strong focus on regional disparities in disease presentation and treatment. Dr. Hirao’s most significant contribution is his leadership in the Asian Prostate Cancer (A-CaP) study, a landmark, Asia-wide initiative launched in 2015. This collaborative project, detailed in his most-cited work (12 citations), aims to systematically survey patient data to clarify the distribution and characteristics of prostate cancer across diverse Asian populations, addressing a critical gap in global oncology. Beyond this, his work includes influential commentary on surgical techniques, such as his evaluation of perioperative outcomes comparing robot-assisted and open radical prostatectomy. Through these efforts, Dr. Hirao has not only generated impactful data but also fostered international collaboration, shaping clinical practices and research priorities for prostate cancer in Asia.